Skip to main navigation Skip to search Skip to main content

Red light photodynamic therapy with 10% aminolevulinic acid gel showed efficacy for treatment of superficial basal cell carcinoma in a randomized, vehicle controlled, double-blind, multicenter phase III study

  • Todd Schlesinger
  • , M. Shane Chapman
  • , John H. Tu
  • , Joel L. Cohen
  • , John Strasswimmer
  • , Nathalie C. Zeitouni
  • , Abel Torres
  • , S. Sasha Jazayeri
  • , Mitchel P. Goldman
  • , Sherrif F. Ibrahim
  • , Edward L. Lain
  • , Megan P. Couvillion
  • , Suzanne Bruce
  • , Vivian T. Laquer
  • , C. William Hanke
  • , David M. Ozog
  • , Jane Schneider
  • , Orit Markowitz
  • , Brian Berman
  • , Mark S. Nestor
  • Michael H. Gold, Girish S. Munavalli, Douglass W. Forsha, Daniel M. Siegel, David Mrohs, Beate Schmitz, Ruth Schäning, Nicole Pospiech, Jon Lyons, Montserrat Foguet, Matthias Lübbert, Hermann Lübbert, David M. Pariser

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Pages (from-to)1489-1498
Number of pages10
JournalJournal of the American Academy of Dermatology
Volume93
Issue number6
DOIs
StatePublished - Dec 2025
Externally publishedYes

ASJC Scopus Subject Areas

  • Dermatology

Keywords

  • 10% ALA gel
  • BF-200 ALA
  • PDT
  • RhodoLED
  • aminolevulinic acid
  • basal cell carcinoma
  • photodynamic therapy
  • randomized clinical trial
  • red light

Cite this